Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?

Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?

Bibliographic Details
Main Authors:	Carlos Escobar, Vivencio Barrios, Luis Manzano
Format:	Article
Language:	English
Published:	Wiley 2019-12-01
Series:	ESC Heart Failure
Online Access:	https://doi.org/10.1002/ehf2.12522

Similar Items

Sacubitril/Valsartan for heart failure
by: Wenqin Dai, MM, et al.
Published: (2022-06-01)

Sacubitril/valsartan: A practical guide
by: Cândida Fonseca, et al.
Published: (2019-05-01)

Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry
by: Aldo P. Maggioni, et al.
Published: (2022-12-01)

The Diuretic Effect of Sacubitril/Valsartan Might Be Clinically Relevant
by: Luís Beck-da-Silva, et al.

Use of sacubitril/valsartan early after CABG
by: Madina Nurzhanova, et al.
Published: (2024-01-01)

Effects of Sacubitril/Valsartan on the Renal Resistance Index
by: Margherita Ilaria Gioia, et al.
Published: (2022-06-01)

Angioedema with concomitant use of sacubitril/valsartan and enalapril
by: Logamoorthy Ramamoorthy, et al.
Published: (2023-01-01)

Sacubitril/valsartan in real-life clinical practice
by: Yüksel Çavuşoğlu
Published: (2021-07-01)

Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
by: Nor Hidayah Mustafa, et al.
Published: (2022-08-01)

Efficacy and safety of sacubitril/valsartan after switching from azilsartan in hemodialysis patients with hypertension
by: Yoshio Iwashima, et al.
Published: (2023-03-01)

Optimal treatment for post-MI heart failure in rats: dapagliflozin first, adding sacubitril-valsartan 2 weeks later
by: Wenqi Tao, et al.
Published: (2023-06-01)

Effects of sacubitril-valsartan in patients undergoing maintenance dialysis
by: Ying Ding, et al.
Published: (2023-12-01)

Sacubitril/Valsartan Ameliorates Crizotinib-Induced Cardiotoxicity in Mice
by: Lijun Cheng, et al.
Published: (2023-07-01)

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
by: Ana Martín‐Garcia, et al.
Published: (2020-04-01)

Renin profiling predicts neurohormonal response to sacubitril/valsartan
by: Giuseppe Vergaro, et al.
Published: (2021-02-01)

Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
by: Sarah L Anderson, et al.
Published: (2018-08-01)

Potential of valsartan+sacubitril therapy in hypertensive heart disease
by: A. G. Ovchinnikov, et al.
Published: (2021-08-01)

Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
by: Burkert Pieske, et al.
Published: (2022-12-01)

Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system
by: Fedor Simko, et al.
Published: (2024-04-01)

Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System
by: Fedor Simko, et al.
Published: (2022-07-01)

Sacubitril/Valsartan Initiation Among Veterans Who Are Renin‐Angiotensin‐Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction
by: April F. Mohanty, et al.
Published: (2021-10-01)

Effects of switching from sacubitril/valsartan to valsartan alone on plasma levels of natriuretic peptides and myocardial remodeling in heart failure with reduced ejection fraction
by: Akihiro Nakamura, et al.
Published: (2023-01-01)

Correction: Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
Published: (2023-03-01)

Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
by: Alex Heyse, et al.
Published: (2019-12-01)

Sacubitril/Valsartan in the Treatment of Resistant Hypertension: Raising Star or Illusion?
by: Marijana Tadic, et al.
Published: (2022-05-01)

The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure
by: Yu Xu, et al.
Published: (2023-05-01)

The efficacy and safety of Sacubitril/Valsartan on pulmonary hypertension in hemodialysis patients
by: Cong Zhao, et al.
Published: (2022-11-01)

Pathogenetic justification of sacubitril / valsartan use in respiratory-cardial comorbidity
by: T. V. Ashcheulova, et al.
Published: (2023-01-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
by: Duygun Altıntaş Aykan, et al.
Published: (2020-10-01)

Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view
by: Borja Quiroga, et al.
Published: (2019-11-01)

Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
by: David Carballo, et al.
Published: (2020-06-01)

Sacubitril/valsartan alleviates myocardial fibrosis in diabetic cardiomyopathy rats
by: Jiao Ai, et al.
Published: (2021-09-01)

Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control
by: Jelena P. Seferovic, et al.
Published: (2020-12-01)

A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan
by: Prashanth Rawla, et al.
Published: (2019-05-01)

Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis
by: Pei Yang, et al.
Published: (2022-08-01)

Sacubitril/valsartan: um importante avanço no puzzle terapêutico da insuficiência cardíaca
by: Pedro Marques da Silva, et al.
Published: (2017-09-01)

EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
by: Zh. D. Kobalava, et al.
Published: (2017-07-01)

Impact of sacubitril/valsartan on cardiac and systemic hypoxia in chronic heart failure
by: Hélène Nougué, et al.
Published: (2024-01-01)

Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure
by: Birju R. Rao, et al.
Published: (2022-06-01)

Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart Failure
by: Maura Brioschi, et al.
Published: (2023-03-01)